Skip to main content
  • kwan-boerneke

    Kwan, Boerneke Support National ‘Penicillin Allergy Awareness Day’ Efforts With Programs that Train Physicians and Benefit Patients

    Led by Millie Kwan, MD, PhD, assistant professor in the division of rheumatology, allergy and immunology, and Renae Boerneke, PharmD, the team has launched an innovative outpatient program where providers de-lable penicillin allergy through penicillin allergy assessments.

  • seth-berkowitz

    Nutrition Insights Features Berkowitz Research and Expanded Study

    Principal Investigator Seth Berkowitz, MD, MPH, with research partners Community Servings and Massachusetts General Hospital, was featured in Nutrition Insights for a study that focuses on using medically tailored meal delivery as an effective health care intervention for diabetes. The five-year research project grant (R01), a $2.9 million NIH grant, will support a randomized cli … Continued

  • David Wohl, MD

    Wohl Tells WRAL News How False Negative Tests For COVID-19 Can Happen

    David Wohl, MD, MPH, professor of medicine in the division of infectious diseases, explained to WRAL News how false negative tests for COVID-19 can occur, and “suggests waiting at least five days or so after exposure before getting tested to be sure and so the end result isn’t a false negative test result.” Wohl also recognized that time is needed for the virus to grow, and “if y … Continued

  • TARGET-NASH Data Publication Finds Nearly One In Five Patients With NAFLD Have Prior Prescription Opioid Use

    Andrew Moon, MD, MPH, a fellow in the division of gastroenterology and hepatology, is lead author of a study finding one in five patients with NAFLD have prior prescription opioid use. Sidney Barritt, MD, MSCR, associate professor, is a co-author. Target RWE, an innovative health evidence solutions company generating real-world evidence (RWE) and delivering regulatory-grade data, … Continued

  • David Wohl, MD

    Wohl Explains Why False Negative Tests Can Happen

    David Wohl, MD, professor of medicine in the division of infectious diseases offered advice on what to do after exposure to the coronavirus. “If you’ve been exposed to a known case of COVID-19, your job is to stay out of circulation, be away from people and then after some time getting a test,” explained Wohl in a WRAL interview. He emphasized that getting tested too early could … Continued

  • David Wohl, MD

    Wohl Featured in UNC Health Media Briefing

    In a new UNC Health Media Briefing on COVID-19, David Wohl, MD, answers questions on topics that include: • What we know about President Donald Trump’s battle with COVID-19. • How UNC Health medical specialists are using Remdesivir and Dexamethasone as well as experimental treatments to help COVID-19 patients. • What the reopening of North Carolina means in the battle against the … Continued

  • CindyGay

    Gay Featured On NPR Talking About Vaccines

    WUNC Producer Charlie Shelton-Ormond talked with Cindy Gay, MD, MPH, associate professor of medicine in the division of infectious diseases, the primary investigator of a Phase 3 clinical trial for a COVID vaccine taking place at UNC-Chapel Hill. Learn more from the UNC Health and UNC School of Medicine Newsroom.

  • hightow-muessig-hovee

    Third Episode of ‘Confronting the HIV Epidemic’ Released

    The third episode of a new series produced by Medscape Video features the work of three members of the UNC Behavior and Technology Lab in the division of infectious diseases. The series, titled “Confronting the HIV Epidemic,” includes interviews with BATLab Director Lisa Hightow-Weidman, MD, MPH; BATLAB Global Division Director Kate Muessig, PhD; and Lina Rosengren-Hovee, MD, MPH … Continued

  • cindy-gay

    Gay Answers Questions About COVID-19 Vaccines and Vaccine Trials

    At the onset of the global pandemic, infectious disease colleagues at Carolina and across the U.S. pivoted quickly and formed the COVID Prevention Network (CoVPN). The network coordinates multiple studies, including the current phase 3 clinical trial for Moderna’s mRNA-1273 COVID-19 vaccine. The overall goal of the national study is to enroll 30,000 volunteers and confirm the vac … Continued

  • david-weber

    Weber Says UNC Tests Every Patient For COVID-19, Pre-Surgery

    David Weber, MD, MPH, professor of medicine in the division of infectious diseases, professor of pediatrics, and professor of epidemiology with the UNC Gillings School of Global Public Health, was featured in a Blue Ridge Public Radio story that recognized how Mission Health decides to test surgery patients for COVID-19.  Weber says testing surgery patients for COVID-19 has becom … Continued